Tycoon Group Holdings Limited (HK:3390)
:3390
Want to see HK:3390 full AI Analyst Report?
3390 Stock Chart & Stats
HK$0.29
HK$0.01(0.29%)
At close: 4:00 PM EST
HK$0.29
HK$0.01(0.29%)
Day’s Range― - ―
52-Week RangeHK$0.22 - HK$0.41
Previous CloseN/A
Volume590.00K
Average Volume (3M)1.30M
Market Cap
HK$227.97M
Enterprise ValueHK$573.17M
Total Cash (Recent Filing)HK$70.34M
Total Debt (Recent Filing)HK$428.05M
Price to Earnings (P/E)14.1
Beta0.03
Next Earnings
Aug 28, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield28%
Share Statistics
EPS (TTM)0.02
Shares Outstanding894,000,000
10 Day Avg. Volume1,126,200
30 Day Avg. Volume1,299,466
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)0.44
Price to Sales (P/S)0.22
P/FCF Ratio2.47
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue And Cash Flow RecoveryA 15.3% revenue rebound in 2025 with operating and free cash flow turning positive (~97M/~96M) indicates the business regained demand traction and restored internal cash generation. Durable positive cash flow strengthens liquidity, funds working capital, and reduces reliance on external financing over the medium term.
Resilient Distribution Business ModelThe core model—distribution of pharmaceuticals and health products to retailers and pharmacies—aligns with stable, non-cyclical end markets. Established channel relationships and recurring procurement/sales cycles support predictable demand and long-term revenue visibility versus discretionary businesses.
Improved Capital Base And Moderate LeverageEquity growth alongside a moderate debt-to-equity ratio (~0.80) provides a firmer capital base to support distribution operations and working capital needs. While debt rose, a strengthened equity position offers financial flexibility to invest in supplier terms, inventory, or selective growth without immediate solvency pressure.
Bears Say
Thin And Declining MarginsMaterially compressed margins—declining gross margin and single-digit operating/net margins—constrain the company's ability to generate sustainable profits from revenue. Low margin structure reduces buffer against cost shocks, limits reinvestment capacity, and makes earnings sensitive to procurement or pricing pressure over the medium term.
High Year-to-year Volatility In ResultsSignificant swings in profitability and cash flows across years undermine predictability of earnings and planning. Volatility complicates forecasting, raises working capital and liquidity planning risks, and reduces confidence that recent improvements will persist absent clearer structural drivers.
Rising Debt And Low Return On EquityMaterial debt increases combined with a low ROE (~2.9%) indicate the business currently struggles to convert capital into attractive returns. Higher indebtedness amplifies financial leverage risk and reduces capacity to pursue growth or weather downturns without further raising financing costs or diluting shareholders.
Tycoon Group Holdings Limited News
3390 FAQ
What was Tycoon Group Holdings Limited’s price range in the past 12 months?
Tycoon Group Holdings Limited lowest stock price was HK$0.22 and its highest was HK$0.41 in the past 12 months.
What is Tycoon Group Holdings Limited’s market cap?
Tycoon Group Holdings Limited’s market cap is HK$227.97M.
When is Tycoon Group Holdings Limited’s upcoming earnings report date?
Tycoon Group Holdings Limited’s upcoming earnings report date is Aug 28, 2026 which is in 67 days.
How were Tycoon Group Holdings Limited’s earnings last quarter?
Tycoon Group Holdings Limited released its earnings results on Mar 31, 2026. The company reported HK$0.026 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.026.
Is Tycoon Group Holdings Limited overvalued?
According to Wall Street analysts Tycoon Group Holdings Limited’s price is currently Overvalued.
Does Tycoon Group Holdings Limited pay dividends?
Tycoon Group Holdings Limited pays a Notavailable dividend of HK$0.035 which represents an annual dividend yield of 28%. See more information on Tycoon Group Holdings Limited dividends here
What is Tycoon Group Holdings Limited’s EPS estimate?
Tycoon Group Holdings Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Tycoon Group Holdings Limited have?
Tycoon Group Holdings Limited has 894,000,000 shares outstanding.
What happened to Tycoon Group Holdings Limited’s price movement after its last earnings report?
Tycoon Group Holdings Limited reported an EPS of HK$0.026 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 5.882%.
Which hedge fund is a major shareholder of Tycoon Group Holdings Limited?
Currently, no hedge funds are holding shares in HK:3390
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Tycoon Group Holdings Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-91.87%
12-Months-Change
Fundamentals
Return on Equity
2.98%
Trailing 12-Months
Asset Growth
16.38%
Trailing 12-Months
Company Description
Tycoon Group Holdings Limited
Tycoon Group Holdings Limited functions as an investment holding enterprise, specializing in the worldwide distribution and retail of an extensive portfolio of health and wellness products. Its market presence extends across Hong Kong, Mainland China, Macau, and various international regions. The company's operations are divided into three distinct divisions: Distribution, E-Commerce, and physical Retail Stores. It offers a diverse selection of goods, including traditional Chinese medicine, nutritional supplements, skincare, personal care items, and other healthcare solutions, sold under both its proprietary labels and third-party brands. Sales channels encompass wholesale distribution to major chain retailers, independent stores, and traders, alongside direct-to-consumer sales through its own network of brick-and-mortar shops and digital platforms. Founded in 2015, the firm is based in Shatin, Hong Kong.
Technical Analysis
Extrawell Pharmaceutical Holdings Limited
―
Kingworld Medicines Group Ltd.
―
PuraPharm Corp. Ltd.
―
New Century Healthcare Holding Co. Ltd.
―
Yestar Healthcare Holdings Co Ltd
―
Options Prices
Currently, No data available
---